Company profilePharmaceutical#703 of 1,318 in Pakistan✓ No DRAP alerts

AL-HAMEED AGENCIES (PVT) LTD.

Pharmaceutical company · 14 brands · 17 molecules

Ranked #41 of 42 companies in Corticosteroid Combinations, Topical

14 registered products 13 pharmaceutical brands 17 distinct molecules 0 DRAP alerts

Company overview

14
registered products
13
pharmaceutical brands
17
distinct molecules
5
therapeutic classes
0
DRAP alerts

AL-HAMEED AGENCIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 14 product registrations across 17 distinct molecules. Its portfolio is concentrated in Corticosteroid Combinations, Topical and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Fluocinolone2 brands
Neomycin1 brand
Tramadol1 brand
Cephazolin1 brand
Sulphur1 brand
Famotidine1 brand
Nalbuphine1 brand
Levodopa.............250Mg Carbidopa ......25Mg1 brand

Therapeutic classes

Corticosteroid Combinations, Topical · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Anti-Parkinson Drugs · 1Emollient And Protective · 1Ace Inhibitor · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 529.97 – Rs 529.97
DVAGO2 products · Rs 104.5 – Rs 204.25
Median across source: Rs 529.97

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for AL-HAMEED

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.